We are live on ! Find out more
Group One Trading

Group One Trading Portfolio holdings

AUM $52.2B
1-Year Est. Return 104.56%
This Fund
S&P 500
This Quarter Est. Return
+4.88%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$6.63B
AUM Growth
+$133M
Cap. Flow
+$377M
Cap. Flow %
5.69%
Top 10 Hldgs %
12.08%
Holding
5,964
New
870
Increased
1,645
Reduced
2,091
Closed
1,097

Sector Composition

Rank Sector Weight
1 Healthcare 2.66%
2 Industrials 2.15%
3 Technology 2.02%
4 Energy 1.33%
5 Consumer Discretionary 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPG
1076
DELISTED
Interpublic Group of Companies
IPG
$896K 0.01%
43,128
-35,420
-45% -$681K
CAG icon
1077
Conagra Brands
CAG
$7.12B
$895K 0.01%
31,684
+7,789
+33% +$213K
VNR
1078
DELISTED
Vanguard Natural Resources, LLC
VNR
$894K 0.01%
59,317
-25,895
-30% -$579K
XLRN
1079
CALL
DELISTED
Acceleron Pharma
XLRN
$892K 0.01%
22,900
+10,200
+80% +$355K
NYNY
1080
DELISTED
Empire Resorts, Inc.
NYNY
$891K 0.01%
22,972
-4,621
-17% -$161K
SUPN icon
1081
CALL
Supernus Pharmaceuticals
SUPN
$2.75B
$890K 0.01%
107,200
-9,200
-8% -$77.3K
TRQ
1082
DELISTED
Turquoise Hill Resources Ltd
TRQ
$890K 0.01%
28,703
-331
-1% -$10.8K
CTRA
1083
PUT
DELISTED
Coterra Energy
CTRA
$882K 0.01%
29,800
-22,600
-43% -$711K
RAI
1084
CALL
DELISTED
Reynolds American Inc
RAI
$881K 0.01%
27,400
-186,800
-87% -$5.92M
EXEL icon
1085
CALL
Exelixis
EXEL
$13.3B
$878K 0.01%
609,600
-163,500
-21% -$255K
OREX
1086
PUT
DELISTED
Orexigen Therapeutics, Inc.
OREX
$875K 0.01%
14,440
-34,800
-71% -$1.75M
SLXP
1087
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$874K 0.01%
+7,606
New +$921K
INSM icon
1088
PUT
Insmed
INSM
$28.3B
$873K 0.01%
56,400
-700
-1% -$9.93K
ZNGA
1089
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$873K 0.01%
328,082
-380,111
-54% -$961K
HOLX
1090
DELISTED
Hologic
HOLX
$872K 0.01%
32,620
+13,792
+73% +$356K
WB icon
1091
PUT
Weibo
WB
$1.94B
$871K 0.01%
61,200
+400
+0.7% +$6.96K
GBX icon
1092
PUT
The Greenbrier Companies
GBX
$1.52B
$870K 0.01%
16,200
+11,400
+238% +$644K
CYTK icon
1093
PUT
Cytokinetics
CYTK
$10.9B
$867K 0.01%
108,300
-59,700
-36% -$256K
STLD icon
1094
CALL
Steel Dynamics
STLD
$37.9B
$867K 0.01%
43,900
-29,700
-40% -$640K
HLT icon
1095
PUT
Hilton Worldwide
HLT
$72.8B
$866K 0.01%
11,067
-6,833
-38% -$512K
RGLS
1096
DELISTED
Regulus Therapeutics
RGLS
$865K 0.01%
+449
New +$799K
ABUS icon
1097
PUT
Arbutus Biopharma
ABUS
$883M
$862K 0.01%
56,900
-8,900
-14% -$154K
ES icon
1098
CALL
Eversource Energy
ES
$26.9B
$862K 0.01%
16,100
-9,100
-36% -$454K
JASO
1099
CALL
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$860K 0.01%
105,100
-3,500
-3% -$29.1K
DMND
1100
PUT
DELISTED
DIAMOND FOODS, INC.
DMND
$858K 0.01%
30,400
-26,900
-47% -$780K

Similar funds

Group One Trading's Q4 2014 Portfolio in Review

As of Q4 2014, Group One Trading held 5,964 positions worth $6.63B, up 2.1% from $6.49B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Group One Trading deployed $377M of net new capital in Q4 2014, opening 870 new positions and adding to 1,645 existing holdings. Its largest new stake was Whiting Petroleum Corporation: 684 shares worth $6.77M.

By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, down from 2.8% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was AstraZeneca, an estimated $11.7M trimmed.

  • Group One Trading's largest Q4 2014 buy was Whiting Petroleum Corporation: 684 shares worth $6.77M.
  • Group One Trading added most to Allergan plc in Q4 2014, an estimated $18.5M increase.
  • Group One Trading's biggest Q4 2014 reduction was AstraZeneca, cutting an estimated $11.7M.
  • Group One Trading fully exited Herc Holdings in Q4 2014, selling an estimated $22.1M.
  • Group One Trading's ten largest holdings make up 12% of its $6.63B portfolio in Q4 2014.
  • Group One Trading opened 870 new positions and closed 1,097 in Q4 2014.
  • Group One Trading's portfolio value rose 2.1% quarter-over-quarter to $6.63B.

Based on Group One Trading's 13F filing for Q4 2014, filed 11 Feb 2015.